1. Home
  2. GYRE vs KLG Comparison

GYRE vs KLG Comparison

Compare GYRE & KLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GYRE
  • KLG
  • Stock Information
  • Founded
  • GYRE 2002
  • KLG 2022
  • Country
  • GYRE United States
  • KLG United States
  • Employees
  • GYRE N/A
  • KLG N/A
  • Industry
  • GYRE Biotechnology: Pharmaceutical Preparations
  • KLG Packaged Foods
  • Sector
  • GYRE Health Care
  • KLG Consumer Staples
  • Exchange
  • GYRE Nasdaq
  • KLG Nasdaq
  • Market Cap
  • GYRE 1.3B
  • KLG 1.5B
  • IPO Year
  • GYRE N/A
  • KLG N/A
  • Fundamental
  • Price
  • GYRE $13.12
  • KLG $17.24
  • Analyst Decision
  • GYRE
  • KLG Hold
  • Analyst Count
  • GYRE 0
  • KLG 8
  • Target Price
  • GYRE N/A
  • KLG $18.88
  • AVG Volume (30 Days)
  • GYRE 53.3K
  • KLG 920.2K
  • Earning Date
  • GYRE 11-13-2024
  • KLG 11-07-2024
  • Dividend Yield
  • GYRE N/A
  • KLG 3.71%
  • EPS Growth
  • GYRE N/A
  • KLG N/A
  • EPS
  • GYRE N/A
  • KLG 0.78
  • Revenue
  • GYRE $105,033,000.00
  • KLG $2,719,000,000.00
  • Revenue This Year
  • GYRE $25.32
  • KLG N/A
  • Revenue Next Year
  • GYRE $12.95
  • KLG N/A
  • P/E Ratio
  • GYRE N/A
  • KLG $22.01
  • Revenue Growth
  • GYRE N/A
  • KLG N/A
  • 52 Week Low
  • GYRE $8.26
  • KLG $10.99
  • 52 Week High
  • GYRE $30.40
  • KLG $24.63
  • Technical
  • Relative Strength Index (RSI)
  • GYRE 41.11
  • KLG 48.33
  • Support Level
  • GYRE $13.07
  • KLG $16.99
  • Resistance Level
  • GYRE $19.00
  • KLG $17.94
  • Average True Range (ATR)
  • GYRE 1.16
  • KLG 0.82
  • MACD
  • GYRE -0.21
  • KLG 0.01
  • Stochastic Oscillator
  • GYRE 7.39
  • KLG 21.77

About GYRE Gyre Therapeutics Inc.

Gyre Therapeutics Inc is a biopharmaceutical company headquartered in San Diego, CA, that is primarily focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis (MASH fibrosis), formerly known as Nonalcoholic Steatohepatitis (NASH)) in the United States. In the United States, Hydronidone is currently being evaluated for the treatment of liver fibrosis across a broad spectrum of chronic liver diseases under an active Investigational New Drug (IND) application. Gyre is also advancing a diverse pipeline in China through a controlling interest in the Beijing Continent, including pirfenidone, F573, F528, and F230.

About KLG WK Kellogg Co

WK Kellogg is the second-largest cereal manufacturer in North America. Its cereal brands include Special K, Frosted Flakes, Raisin Bran, Froot Loops, Frosted Mini Wheats, Kashi, Corn Flakes, Rice Krispies, Apple Jacks, and Bear Naked. The company was spun off from the former Kellogg business, now known as Kellanova, where the former firm's global snacks portfolio and international cereal brands are now housed. WK Kellogg, which began trading independently in October 2023, generates the bulk of its sales (about 88% of its fiscal 2023 base) from the US.

Share on Social Networks: